Fadaei et al. [36] found a significantly lower serum level of adipolin in patients with coronary artery disease than control patients, suggesting a possible link between adipolin and the pathogenic mechanisms of atherosclerosis, such as inflammation and high-density lipoprotein–cholesterol metabolism. The gene discussed is C1QTNF12; the disease is coronary artery disorder.